PubRank

Wen-Mei Fu

Author PubWeight™ 60.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med 2010 1.78
2 Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Ultrasound Med Biol 2007 1.64
3 Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole. Mol Pharmacol 2003 1.63
4 Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 2007 1.59
5 Autophagy protects neuron from Abeta-induced cytotoxicity. Autophagy 2009 1.36
6 SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol 2009 1.35
7 Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 pathway in microglia. J Immunol 2007 1.24
8 Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol Pharmacol 2006 1.16
9 Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia 2009 1.15
10 Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. J Neurosci 2007 1.13
11 Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages. Br J Pharmacol 2003 1.12
12 Quantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain-barrier disruption. Ultrason Sonochem 2007 1.12
13 Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol Pharmacol 2007 1.12
14 Regulation by ultrasound treatment on the integrin expression and differentiation of osteoblasts. Bone 2005 1.11
15 Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts. J Biol Chem 2005 1.09
16 Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis 2007 1.07
17 PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone 2007 1.06
18 Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol Pharmacol 2007 1.03
19 Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia 2008 1.00
20 Ultrasound induces cyclooxygenase-2 expression through integrin, integrin-linked kinase, Akt, NF-kappaB and p300 pathway in human chondrocytes. Cell Signal 2007 1.00
21 Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase C alpha, c-Src, NF-kappa B and p300 pathway. Mol Immunol 2007 1.00
22 Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1. Eur J Neurosci 2005 0.99
23 Inhibition of tumor formation by snake venom disintegrin. Toxicon 2005 0.99
24 Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells. J Cell Physiol 2009 0.99
25 Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochem Pharmacol 2006 0.98
26 Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. Prostate 2008 0.98
27 Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes. Mol Pharmacol 2007 0.96
28 Ultrasound induces hypoxia-inducible factor-1 activation and inducible nitric-oxide synthase expression through the integrin/integrin-linked kinase/Akt/mammalian target of rapamycin pathway in osteoblasts. J Biol Chem 2007 0.95
29 Hypoxia-induced matrix metalloproteinase-13 expression in astrocytes enhances permeability of brain endothelial cells. J Cell Physiol 2009 0.94
30 Osteoblast-derived TGF-beta1 stimulates IL-8 release through AP-1 and NF-kappaB in human cancer cells. J Bone Miner Res 2008 0.92
31 A forward loop between glioma and microglia: glioma-derived extracellular matrix-activated microglia secrete IL-18 to enhance the migration of glioma cells. J Cell Physiol 2012 0.91
32 Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol Pharmacol 2008 0.91
33 Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. J Cell Physiol 2010 0.89
34 Expression of neurotrophic factors in neonatal rats after peripheral inflammation. J Pain 2006 0.89
35 Basic fibroblast growth factor stimulates fibronectin expression through phospholipase C gamma, protein kinase C alpha, c-Src, NF-kappaB, and p300 pathway in osteoblasts. J Cell Physiol 2007 0.89
36 Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate. Eur J Pharmacol 2008 0.89
37 Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Eur J Pharmacol 2007 0.88
38 Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1. J Neurochem 2011 0.88
39 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. J Cell Physiol 2011 0.87
40 The mechanism of heme oxygenase-1 action involved in the enhancement of neurotrophic factor expression. Neuropharmacology 2009 0.87
41 Prevalence of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Taiwanese patients with Type 2 diabetic mellitus. Clin Biochem 2011 0.85
42 Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice. J Biol Chem 2006 0.84
43 Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts. J Cell Physiol 2013 0.84
44 Enhancement of fibronectin synthesis and fibrillogenesis by BMP-4 in cultured rat osteoblast. J Bone Miner Res 2003 0.83
45 Enhancement of active shuttle avoidance response by the NO-cGMP-PKG activator YC-1. Eur J Pharmacol 2008 0.83
46 Inhibition of adipogenesis by RGD-dependent disintegrin. Biochem Pharmacol 2005 0.83
47 Upregulation of drug transporter expression by osteopontin in prostate cancer cells. Mol Pharmacol 2013 0.83
48 The effects of low-intensity ultrasound on growing bone after sciatic neurectomy. Ultrasound Med Biol 2005 0.83
49 Enhancement of fibronectin fibrillogenesis and bone formation by basic fibroblast growth factor via protein kinase C-dependent pathway in rat osteoblasts. Mol Pharmacol 2004 0.81
50 Differential regulation of fibronectin fibrillogenesis by protein kinases A and C. Connect Tissue Res 2002 0.81
51 Differential susceptibility of osteosarcoma cells and primary osteoblasts to cell detachment caused by snake venom metalloproteinase protein. Toxicon 2004 0.80
52 Regulation of fibronectin fibrillogenesis by protein kinases in cultured rat osteoblasts. Mol Pharmacol 2002 0.80
53 Enhancement role of host 12/15-lipoxygenase in melanoma progression. Eur J Cancer 2013 0.79
54 Involvement of 15-lipoxygenase in the inflammatory arthritis. J Cell Biochem 2012 0.79
55 Acetazolamide impairs fear memory consolidation in rodents. Neuropharmacology 2012 0.79
56 Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation. Osteoporos Int 2013 0.79
57 Ethanol Extracts of Fresh Davallia formosana (WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor- κ B Activation. Evid Based Complement Alternat Med 2013 0.78
58 CXCL12/CXCR4 Signaling Contributes to the Pathogenesis of Opioid Tolerance: A Translational Study. Anesth Analg 2017 0.77
59 Metabolomic Dynamic Analysis of Hypoxia in MDA-MB-231 and the Comparison with Inferred Metabolites from Transcriptomics Data. Cancers (Basel) 2013 0.77
60 Enhancement of PLGF production by 15-(S)-HETE via PI3K-Akt, NF-κB and COX-2 pathways in rheumatoid arthritis synovial fibroblast. Eur J Pharmacol 2013 0.77
61 Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. Neuropharmacology 2013 0.77
62 Increase of oxidative stress by a novel PINK1 mutation, P209A. Free Radic Biol Med 2012 0.76
63 Role of spinal CXCL1 (GROα) in opioid tolerance: a human-to-rodent translational study. Anesthesiology 2015 0.75
64 Ultrasound stimulates MMP-13 expression through p38 and JNK pathway in osteoblasts. J Cell Physiol 2008 0.75
65 Attention-deficit/hyperactivity disorder-related symptoms improved with allergic rhinitis treatment in children. Am J Rhinol Allergy 2016 0.75
66 Low-intensity pulsed ultrasound-promoted bone healing is not entirely cyclooxgenase 2 dependent. J Ultrasound Med 2008 0.75
67 Inhibition of hyperactivity and impulsivity by carbonic anhydrase inhibitors in spontaneously hypertensive rats, an animal model of ADHD. Psychopharmacology (Berl) 2015 0.75
68 Novel Pyrazole Derivatives Effectively Inhibit Osteoclastogenesis, a Potential Target for Treating Osteoporosis. J Med Chem 2015 0.75